Effect of Hepatosteatosis on the Virological Response in Entecavir and Tenofovir Therapies

Creative Commons License

KORKMAZ P., Demirturk N., Batirel A., Tulek N., Ozguler M., Harman R., ...More

KLIMIK JOURNAL, vol.32, no.3, pp.265-274, 2019 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 32 Issue: 3
  • Publication Date: 2019
  • Doi Number: 10.5152/kd.2019.73
  • Journal Name: KLIMIK JOURNAL
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus
  • Page Numbers: pp.265-274
  • Hacettepe University Affiliated: Yes


Objective: Both chronic hepatitis B (CHB) and hepatosteatosis may lead to necroinflammation in liver. Therefore, the presence of hepatosteatosis might negatively affect the efficacy of antiviral therapy. We aimed to determine the effect of hepatosteatosis on virological response in patients with CHB receiving entecavir (ETV) and tenofovir (TDF) treatment.